Cite

HARVARD Citation

    Ponziani, F. et al. (2016). Rifaximin for the treatment of irritable bowel syndrome – a drug safety evaluation. Expert opinion on drug safety. 15 (7), pp. 983-991. [Online]. 
  
Back to record